Scarica l'app Stockscreener
3.83
1.54%
-0.06
Dopo l'orario di chiusura:
3.88
0.05
+1.31%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Altimmune Inc Borsa (ALT) Ultime notizie
What MACD and RSI say about Altimmune Inc.Stop Loss & Intraday High Probability Setup Alerts - newser.com
Does Altimmune Inc. show high probability of reboundShare Buyback & Community Consensus Trade Alerts - newser.com
Historical volatility pattern of Altimmune Inc. visualized2025 Short Interest & Reliable Price Action Trade Plans - newser.com
How to manage a losing position in Altimmune Inc.Weekly Stock Report & Technical Confirmation Trade Alerts - newser.com
How to use Fibonacci retracement on Altimmune Inc.Trade Performance Summary & Precise Swing Trade Alerts - newser.com
Important Notice to Long-Term Shareholders of Altimmune, Inc. (NASDAQ: ALT); Five Below, Inc. ... - Caledonian Record
Important Notice to Long-Term Shareholders of Altimmune, - GlobeNewswire
Biopharma's New MASH Drug Has Two MOAs - streetwisereports.com
Backtesting results for Altimmune Inc. trading strategiesJuly 2025 Market Mood & Low Risk Investment Opportunities - newser.com
Using fundamentals and technicals on Altimmune Inc.Short Setup & Smart Money Movement Alerts - newser.com
Altimmune, Inc. (NASDAQ: ALT) Long Term Investor Alert: Investigation of potential Wrongdoing - openPR.com
Altimmune, Inc.Common Stock (NQ: - FinancialContent
Altimmune rises as buyout rumors follow R&D updates - MSN
Altimmune (NASDAQ:ALT) Receives Buy Rating from HC Wainwright - MarketBeat
ALT Stock: HC Wainwright & Co. Reiterates 'Buy' Rating with $12 - GuruFocus
Altimmune, Inc. (ALT) Stock Analysis: Exploring A 311% Potential Upside In Biotech - DirectorsTalk Interviews
Altimmune, Inc. (NASDAQ:ALT) Receives Average Rating of “Hold” from Analysts - Defense World
Altimmune, Inc. (NASDAQ:ALT) Receives Average Rating of "Hold" from Analysts - MarketBeat
ALTIMMUNE ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Altimmune, Inc. (ALT1.MX) Stock Price, News, Quote & History - Yahoo
Pleasing Signs As A Number Of Insiders Buy Altimmune Stock - Yahoo Finance
PFG Investments LLC Has $46,000 Stock Position in Altimmune, Inc. $ALT - Defense World
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc.(ALT) Shareholders - Sahm
Join Class Action to Recover Losses from Altimmune, Inc. (ALT)Contact Levi & Korsinsky Before October 6, 2025 - ACCESS Newswire
Investors who lost money on Altimmune, Inc. (ALT) should contact Levi & Korsinsky about pending Class ActionALT - GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - FinancialContent
October 6, 2025 Deadline Approaching: Join Class Action Against Altimmune, Inc. (ALT)Contact Levi & Korsinsky - ACCESS Newswire
ALTIMMUNE FINAL DEADLINE REMINDER: Bragar Eagel & Squire, - GlobeNewswire
Securities Fraud Class Action Filed Against Altimmune, Inc. (ALT)Levi & Korsinsky Reminds Investors of October 6, 2025 - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Altimmune, Inc. (ALT) Investors of October 6, 2025 Deadline - ACCESS Newswire
ALT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - FinancialContent
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Recover Investment Losses: Levi & Korsinsky Files Class Action Against Altimmune, Inc. (ALT) - ACCESS Newswire
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Altimmune Appoints New Chief Medical Officer - The Globe and Mail
Faruqi & Faruqi Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 6, 2025ALT - Newsfile
ALT FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING FIRM, - GlobeNewswire
ALTIMMUNE CLASS ACTION REMINDER: Bragar Eagel & Squire, - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming DeadlinesALT - cnhinews.com
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - MarketScreener
ALT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Altimmune, Inc. to Contact the Firm Today! - ACCESS Newswire
Altimmune, Inc. Class Action: Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 6, 2025ALT | Dow Theory Letters - FinancialContent
ALT Deadline: ALT Investors with Losses in Excess of $50K Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit - Morningstar
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securitie - GuruFocus
Investors SueWallSt Over Altimmune, Inc. Stock DropContact Levi & Korsinsky to Join - ACCESS Newswire
Shareholders that lost money on Altimmune, Inc.(ALT) Urged - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - Newsfile
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):